Thursday, January 1st |
||
12:00 PM (5 hours) |
Happy New Year's New Year's Day |
E&R 2071 |
Thursday, January 8th |
||
8:00 AM (4 hours) |
Citywide Tox Rounds Sinai-Grace |
Sinai-Grace Auditorium |
Thursday, January 15th |
||
11:00 AM |
When Do We Start Giving FFP In Massive Blood Loss? Dr. Reifel-Saltzberg |
E&R 2071 |
12:00 PM |
DEM Trauma Rounds Dept Of Emergency Medicine |
E&R 2071 |
1:00 PM (2 hours) |
Pediatrics Dr. J. Hays |
E&R 2071 |
3:00 PM |
EBM Part 1 Dr. Goyal |
E&R 2071 |
Thursday, January 22nd |
||
11:00 AM |
Case Follow Up Lecture Dr. Yucebay/ Dr. English |
E&R 2071 |
12:00 PM |
Post L&D Complications Dr. Kirkpatrick |
E&R 2071 |
1:00 PM |
M&M Chief Residents |
E&R 2071 |
2:00 PM |
Tox Rounds Dr. Baltarowich |
E&R 2071 |
3:00 PM |
Is There Utility To Using Hypertonic Saline In Fluid Resuscitation? Dr. Connor |
E&R 2071 |
Thursday, January 29th |
||
11:00 AM |
Endocrinologic Emergencies Dr. Brauer |
E&R 2071 |
12:00 PM |
ENT In Service Review Dr. Slezak |
E&R 2071 |
1:00 PM |
OB/GYN/GU In Service Review Dr. Vallee |
E&R 2071 |
2:00 PM |
Ophthalmology In Service Review Dr. Goyal |
E&R 2071 |
3:00 PM |
Pre Hospital And Disaster In Service Review Dr. Klausner |
E&R 2071 |
Last updated: 12-9-2008 11:48 AM
ACCREDITATION STATEMENT: Henry Ford Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Henry Ford Health System takes responsibility for the content, quality, and scientific integrity of this CME activity. DESIGNATION STATEMENT: Henry Ford Health System designates this educational activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity. In the State of Michigan, Category 1 physician credits are applicable to nursing contact hours. FACULTY DISCLOSURE STATEMENT: All faculty and planning committee members participating in continuing education activities sponsored by Henry Ford Health System are required to disclose to the audience any relevant commercial relationships, and/or non-FDA approved use of a drug or a device that is included in the presentation.